Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

ICZOOM Group Inc. (IZM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W
6.93-0.02 (-0.29%)
At close: 03:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Inside Bar (Bullish)

Inside Bar (Bullish)

Performance Outlook
Previous Close6.95
Open7.05
Bid6.62 x 800
Ask7.18 x 1100
Day's Range6.68 - 7.24
52 Week Range1.61 - 12.87
Volume52,042
Avg. Volume76,619
Market Cap71.562M
Beta (5Y Monthly)N/A
PE Ratio (TTM)30.13
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
15% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for IZM

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ICZOOM Group Inc.
    Analyst Report: Eli Lilly and CompanyEli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
    Rating
    Fair Value
    Economic Moat
    7 days agoMorningstar
View more
Advertisement
Advertisement